Aldeyra Therapeutics Inc (ALDX)
4.105
-0.08
(-2.03%)
USD |
NASDAQ |
May 02, 10:43
Aldeyra Therapeutics Cash and Short Term Investments (Quarterly): 142.82M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 142.82M |
| September 30, 2023 | 143.33M |
| June 30, 2023 | 151.68M |
| March 31, 2023 | 165.03M |
| December 31, 2022 | 174.30M |
| September 30, 2022 | 185.33M |
| June 30, 2022 | 196.69M |
| March 31, 2022 | 216.87M |
| December 31, 2021 | 229.79M |
| September 30, 2021 | 241.37M |
| June 30, 2021 | 249.74M |
| March 31, 2021 | 138.44M |
| December 31, 2020 | 77.86M |
| September 30, 2020 | 86.18M |
| June 30, 2020 | 66.19M |
| March 31, 2020 | 61.38M |
| December 31, 2019 | 73.36M |
| September 30, 2019 | 76.17M |
| June 30, 2019 | 69.46M |
| March 31, 2019 | 82.12M |
| December 31, 2018 | 93.60M |
| September 30, 2018 | 35.14M |
| Date | Value |
|---|---|
| June 30, 2018 | 41.68M |
| March 31, 2018 | 38.94M |
| December 31, 2017 | 42.95M |
| September 30, 2017 | 47.91M |
| June 30, 2017 | 25.82M |
| March 31, 2017 | 31.21M |
| December 31, 2016 | 24.91M |
| September 30, 2016 | 28.88M |
| June 30, 2016 | 32.55M |
| March 31, 2016 | 23.03M |
| December 31, 2015 | 27.59M |
| September 30, 2015 | 30.62M |
| June 30, 2015 | 33.57M |
| March 31, 2015 | 15.72M |
| December 31, 2014 | 8.527M |
| September 30, 2014 | 10.14M |
| June 30, 2014 | 11.54M |
| March 31, 2014 | 2.146M |
| December 31, 2013 | 3.262M |
| September 30, 2013 | 2.764M |
| December 31, 2012 | 1.224M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
61.38M
Minimum
Mar 2020
249.74M
Maximum
Jun 2021
144.53M
Average
143.33M
Median
Sep 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| AbbVie Inc | 12.82B |
| United Therapeutics Corp | 2.994B |
| Heron Therapeutics Inc | 80.41M |
| Esperion Therapeutics Inc | 82.25M |
| FibroGen Inc | 235.59M |